Whalegun
Home

Regeneron Pharmaceuticals REGN spent $430K on lobbying in Q4 2023 · Health Issues, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$430,000
Quarter
Q4 2023
Stock
Regeneron Pharmaceuticals REGN
Client
Regeneron Pharmaceuticals
Reported
24/01/22

Up 7.5% from last quarter

What else happened in Regeneron Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Regeneron Pharmaceuticals's other lobbying reports

Regeneron Pharmaceuticals REGN spent $430K on lobbying in Q4 2023 · Health Issues, Medicare and 1 more issue | Whalegun